COMMUNIQUÉS West-GlobeNewswire

REPEAT - Hemispherx Biopharma’s CEO to Present at the 15th Annual NobleConXV Conference
24/01/2019
OCALA, Fla., Jan. 24, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc., an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, announced [...]
Neovacs to present full results from the Phase IIb IFNalpha Kinoid clinical study at the 13th International Lupus Congress
24/01/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT FULL RESULTS FROM THE PHASE IIb IFNalpha KINOID CLINICAL STUDY AT THE 13 TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019) 5 - 9 APRIL, SAN FRANCISCO Paris [...]
Néovacs présentera les résultats complets de l'étude clinique de Phase IIb avec l'IFNalpha Kinoïde au 13th International Lupus Congress
24/01/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTERA LES RÉSULTATS COMPLETS DE L’ÉTUDE CLINIQUE DE PHASE IIb AVEC l’IFNα Kinoïde AU 13 TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019) 5 - 9 [...]
Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz
24/01/2019
CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for [...]
ATW Tech Announces Appointment on its Management Team
24/01/2019
MONTREAL, Jan. 24, 2019 (GLOBE NEWSWIRE) -- The Founder, President and Chief Executive Officer of ATW Tech Inc. (“ ATW Tech ”) (TSX-V: ATW), Mr. Michel Guay, is pleased to announce the appointment of Mr. Denis LP [...]
ATW Tech annonce une nomination à son équipe de direction
24/01/2019
MONTRÉAL, 24 janv. 2019 (GLOBE NEWSWIRE) -- Le fondateur, président et chef de la direction d’ATW Tech Inc. (« ATW Tech ») ( TSX-V : ATW ), M. Michel Guay, est heureux d’annoncer la nomination de M. Denis LP Archambault [...]
Generex Subsidiary NuGenerex Diagnostics Announces CE-Mark Certification for its Rapid Point-of-Care Express II Syphilis Treponemal Assay
24/01/2019
-- Rapid point-of-care syphilis assay -- Cleared for sale in the European Union -- Addressing the emerging global syphilis resurgence MIRAMAR, FL, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NuGenerex [...]
Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares
24/01/2019
CAMBRIDGE, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a genetic medicines company focused on delivering transformational therapies for patients with serious, genetically-defined [...]
Arch Biopartners Arranges Convertible Note Financing
24/01/2019
TORONTO, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing [...]
Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Ointment USP, 0.05%
24/01/2019
BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
ChemoCentryx Announces Withdrawal of Phase II-Based Conditional Marketing Authorization (CMA) Application for ANCA-Associated Vasculitis in Europe; Phase III ADVOCATE Trial Data Release Planned for Q4 2019
24/01/2019
-- Companies plan to file for full marketing approval to EMA and FDA in 2020 -- MOUNTAIN VIEW, Calif. and ZURICH, Switzerland, Jan. 24, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. and Vifor Fresenius Medical Care Renal [...]
CFN Media's Exclusive Executive Interview With Grown Rogue on Michigan Expansion
24/01/2019
Seattle, Washington, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Kane Biotech Secures Largest Single Order of bluestem™ products
24/01/2019
C$440K Order from Major North American Retailer. WINNIPEG, Manitoba, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), is pleased to announced that it [...]
Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
24/01/2019
NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical [...]
Trident Brands Inc. Subsidiary Brain Armor® Signs NFL Hall of Famer Randy White as National Brand Ambassador
24/01/2019
Brookfield, WI, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, today announced it has signed NFL Hall of Famer Randy White as National Brand [...]
Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
24/01/2019
Results supported the design of ongoing pivotal study and FDA Breakthrough Therapy designation WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, [...]
TESARO, Inc. Provides Notice of Fundamental Change, Conversion Rate Adjustment pursuant to Make-Whole Adjustment Event and Supplemental Indenture
24/01/2019
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- TESARO, Inc. (the “ Company ” or “ TESARO ”), an oncology-focused biopharmaceutical company, today announced that pursuant to the terms of the Indenture and the First [...]
InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study Comparing CGuard™ EPS with a Conventional Open-Cell Carotid Stent
24/01/2019
CGuard™ EPS shows encouraging interim results verses a conventional carotid stent in absence of any adverse clinical events in the CGuard™ arm Data presented at the LINC 2019 Congress in Leipzig, Germany TEL AVIV, [...]
Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
24/01/2019
VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of [...]

Pages